Sandy D Balkin

Sandy is SVP Strategy and Analytics at Royalty Pharma, an investment company that purchases economic interests in pharmaceutical products. He is responsible for building and managing a cross-functional team charged with leveraging unstructured data to identify and support investment opportunities. Prior to joining Royalty Pharma, Sandy was Managing Director and Leader of the Truist Securities’ Data Science and Engineering research team developing capabilities in data science, machine learning and alternative data and integrating them into quantamental investment research. Over his career, he has built and led advanced business analytics functions at top pharmaceutical companies including Pfizer, Boehringer Ingelheim, and Sanofi.

Sandy has a Ph.D. in Business Administration from Penn State University. He also holds a Master of Arts in Statistics from Penn State University, as well as a Bachelor of Arts Degree in Mathematics and Economics and Music from Lafayette College where he graduated with honors.